File photo
File photo
Dallas Regional Chamber Senior Vice President of Economic Development Mike Rosa recently released a statement describing the Dallas-Fort Worth area as an emerging hub for the biotech and life sciences sectors.
Biotech and life science companies generally cluster together when choosing where to build facilities, invest and create jobs. Boston, San Francisco, San Diego, Washington D.C., Raleigh-Durham and other areas feature desirable biotechnology ecosytems that feature great research universities, a large talent pool, lab space, patent generation, and funding from venture capital firms or the National Institutes of Health.
Within recent years, the Dallas Regional Chamber has led bids that promoted DFW as a finalist for new biotech manufacturing facilities by Genentech, Novartis, and others.
The companies were attracted by the area’s strength as a place to do business as well as other leading biotech companies in the area including Alcon in Fort Worth and UT Southwestern Medical Center in Dallas. With a funding level of about $470 million annually and the only academic medical center in the world to serve as home to six Nobel Laureates, UT Southwestern Medical Center is the area’s leading biotech company. It trains 3,600 medical professionals each year and conducts research and launches companies across a variety of biomedical fields.
DFW is quickly catching up with the established Biotech and life science hubs and objective third parties are taking notice. CBRE recently ranked DFW sixth on a top 10 list of emerging life science clusters in the U.S in an October 2020 life science cluster report.
Alerts Sign-up